| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000029735 |
| Receipt No. | R000033974 |
| Official scientific title of the study | A study of the effect of the food ingredients on muscle strength in human lower limb. |
| Date of disclosure of the study information | 2019/06/29 |
| Last modified on | 2019/02/07 (Ver. 7) |
| Basic information | ||
| Official scientific title of the study | A study of the effect of the food ingredients on muscle strength in human lower limb. | |
| Title of the study (Brief title) | A study of the effect of the food ingredients on muscle strength in human lower limb. | |
| Region |
|
|
| Condition | ||
| Condition | Not applicable | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the effect of the food ingredients on muscle strength in human lower limb. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The stage of the locomotive syndrome risk based on the stand-up test at the 12th week of intake. |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Supplement containing food
ingredients such as glucosamine, 12 weeks. |
|
| Interventions/Control_2 | Supplement not containing food
ingredients such as glucosamine, 12 weeks. |
|
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Women and men aged 55 to 74 years at the time of acquisition of agreement in participating in this study
2) Presence of knee pain 3) Person who begins declining in mobility, especially who begins declining muscle strength in lower limb and deteriorating physical condition and lifestyles 4) Person who can come to the medical organization for the measurement at the date of visiting 5) Person who can understand the purpose and content of this study and agree in writing to participate in this study |
|||
| Key exclusion criteria | 1) Kellgren - Lawrence grades 2-4
2) Presence of hyperuricemia 3) Presence of rheumatoid arthritis that may cause joint pain 4) Surgical treatment of knee joint(s) needed or undergone 5) Need for pharmacological articular treatments during the study period 6) Presence of history of osseous or articular diseases other than OA within the past 3 months 7) Presence of disease in locomotor organs that affects the efficacy assessment of this study 8) Use of product affecting the data of this study, such as medicine, food for specified health use, or health food 9) Daily use of a cane or a supporter 10) Daily use of hot spa or massage therapy 11) Daily or occasional vigorous exercise 12) Female in pregnancy, lactation and scheduled pregnancy period 13) With present heart disorder, liver disorder, kidney disorder, diabetes mellitus, or obesity, with previous or present cardiac disorder, or with allergy to the study foods 14) Investigator's judgment for other reason |
|||
| Target sample size | 140 | |||
| Research contact person | |
| Name of lead principal investigator | Junichi Nakamura |
| Organization | Suntory MONOZUKURI Expert Limited |
| Division name | R&D Support Department HE Center |
| Address | 2-3-3 Daiba, Minato-ku, Tokyo, Japan |
| TEL | 03-5579-1277 |
| Junichi_Nakamura@suntory.co.jp | |
| Public contact | |
| Name of contact person | Akifumi Maeda |
| Organization | Suntory MONOZUKURI Expert Limited |
| Division name | R&D Support Department HE Center |
| Address | 8-1-1 Seikadai, Seika-cho, Soraku-gun, Kyoto, Japan |
| TEL | 050-3182-0719 |
| Homepage URL | |
| Akifumi_Maeda@suntory.co.jp | |
| Sponsor | |
| Institute | Suntory MONOZUKURI Expert Limited |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Suntory Wellness Limited |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033974 |